Colorectal Carcinoma with Extremely Low CA19-9

Aim. The aim of this study is to determine the significance of postoperative sequential measurements of serum CA19-9 in patients with extremely low serum level. Patients and Methods. Serum level of CA19-9 of 1096 patients who underwent surgery was measured preoperatively and every three months after...

Full description

Saved in:
Bibliographic Details
Main Authors: Yutaka J. Kawamura, Aika Tokumitsu, Junichi Sasaki, Shingo Tsujinaka, Takafumi Maeda, Ken Mizogami, Fumio Konishi
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2009/780263
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547308618645504
author Yutaka J. Kawamura
Aika Tokumitsu
Junichi Sasaki
Shingo Tsujinaka
Takafumi Maeda
Ken Mizogami
Fumio Konishi
author_facet Yutaka J. Kawamura
Aika Tokumitsu
Junichi Sasaki
Shingo Tsujinaka
Takafumi Maeda
Ken Mizogami
Fumio Konishi
author_sort Yutaka J. Kawamura
collection DOAJ
description Aim. The aim of this study is to determine the significance of postoperative sequential measurements of serum CA19-9 in patients with extremely low serum level. Patients and Methods. Serum level of CA19-9 of 1096 patients who underwent surgery was measured preoperatively and every three months after surgery for 5 years. Patients with CA19-9 level of less than 2 U/mL at the time of diagnosis were defined as Extremely Low CA19-9 (ELCA). Results. One hundred and seven patients (9.8%) were ELCA. Of these, 86 underwent surgery with curative intent. Serum levels of CA19-9 in patients who did not undergo curative resection (𝑁=12) and who developed recurrence (𝑁=10) were less than 2.0 U/mL in all occasions during followup. In all patients without recurrence, serum level of CA19-9 also remained less than 2.0 U/mL. Conclusion. In patients with extremely low CA19-9, who consist of 9.8% of colorectal carcinoma cases, postoperative sequential measurement of serum level of CA19-9 contributed neither to assessment of curability of surgical resection nor to detection of recurrence.
format Article
id doaj-art-9f045b0bbd9e497a8e1caf4778989035
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-9f045b0bbd9e497a8e1caf47789890352025-02-03T06:45:19ZengWileyGastroenterology Research and Practice1687-61211687-630X2009-01-01200910.1155/2009/780263780263Colorectal Carcinoma with Extremely Low CA19-9Yutaka J. Kawamura0Aika Tokumitsu1Junichi Sasaki2Shingo Tsujinaka3Takafumi Maeda4Ken Mizogami5Fumio Konishi6Department of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanDepartment of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanDepartment of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanDepartment of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanDepartment of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanDepartment of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanDepartment of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, JapanAim. The aim of this study is to determine the significance of postoperative sequential measurements of serum CA19-9 in patients with extremely low serum level. Patients and Methods. Serum level of CA19-9 of 1096 patients who underwent surgery was measured preoperatively and every three months after surgery for 5 years. Patients with CA19-9 level of less than 2 U/mL at the time of diagnosis were defined as Extremely Low CA19-9 (ELCA). Results. One hundred and seven patients (9.8%) were ELCA. Of these, 86 underwent surgery with curative intent. Serum levels of CA19-9 in patients who did not undergo curative resection (𝑁=12) and who developed recurrence (𝑁=10) were less than 2.0 U/mL in all occasions during followup. In all patients without recurrence, serum level of CA19-9 also remained less than 2.0 U/mL. Conclusion. In patients with extremely low CA19-9, who consist of 9.8% of colorectal carcinoma cases, postoperative sequential measurement of serum level of CA19-9 contributed neither to assessment of curability of surgical resection nor to detection of recurrence.http://dx.doi.org/10.1155/2009/780263
spellingShingle Yutaka J. Kawamura
Aika Tokumitsu
Junichi Sasaki
Shingo Tsujinaka
Takafumi Maeda
Ken Mizogami
Fumio Konishi
Colorectal Carcinoma with Extremely Low CA19-9
Gastroenterology Research and Practice
title Colorectal Carcinoma with Extremely Low CA19-9
title_full Colorectal Carcinoma with Extremely Low CA19-9
title_fullStr Colorectal Carcinoma with Extremely Low CA19-9
title_full_unstemmed Colorectal Carcinoma with Extremely Low CA19-9
title_short Colorectal Carcinoma with Extremely Low CA19-9
title_sort colorectal carcinoma with extremely low ca19 9
url http://dx.doi.org/10.1155/2009/780263
work_keys_str_mv AT yutakajkawamura colorectalcarcinomawithextremelylowca199
AT aikatokumitsu colorectalcarcinomawithextremelylowca199
AT junichisasaki colorectalcarcinomawithextremelylowca199
AT shingotsujinaka colorectalcarcinomawithextremelylowca199
AT takafumimaeda colorectalcarcinomawithextremelylowca199
AT kenmizogami colorectalcarcinomawithextremelylowca199
AT fumiokonishi colorectalcarcinomawithextremelylowca199